Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients
ar.iiarjournals.org/content/37/6/3169.shortPosted Jun 3, 2017, 4:56 PM UTC
10
ar.iiarjournals.org
Loading comments…
Posted Jun 3, 2017, 4:56 PM UTC